Skip to content

ER4-13

by Sonoscape Medical Corp. 2 variants

Part of a family of 36 devices: see the family page

Ref _Model 6V3

ER4-13 (_) is a medical device (EU MDR Class IIa; EMDN category endocavitary ultrasound probes) made by Sonoscape Medical Corp., registered in EUDAMED on 24 Sep 2023 (Basic UDI-DI 69458686P1009R2), active as of 22 Oct 2026.

Active European Union

CE MDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number69458686P1009R2 Basic UDI-DI 06945868615406UDI-DIDate24 Sep 2023RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device name
Ultrasonic Transducer
Model / reference
6V3, _
Primary DI / UDI-DI
06945868615406
Basic UDI-DI
69458686P1009R2
Direct marketing DI
06945868615406
EMDN code
Z1104020201 Endocavitary ultrasound probes, two–dimensional
Device class
Class IIa
EU registration type
Standard device
EU market of registration
Netherlands

Manufacturer details

EUDAMED SRN
CN-MF-000009623
Authorised representative
Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001

Similar devices in this category

Other devices filed under ENDOCAVITARY ULTRASOUND PROBES, TWO–DIMENSIONAL.

Other devices from Sonoscape Medical Corp.

See all devices from Sonoscape Medical Corp. →

Properties

Other properties (14, all answered No)